Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: Results from the HIJAMI-II registry

Heart

Volumn 95, Issue 3, 2009, Pages 216-220

  Shiga, T ^a   Hagiwara, N ^a   Ogawa, H ^a   Takagi, A ^a   Nagashima, M ^a   Yamauchi, T ^a   Tsurumi, Y ^a   Koyanagi, R ^a   Kasanuki, H ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; AGED; ARTICLE; COHORT ANALYSIS; CORONARY ARTERY BYPASS SURGERY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK POPULATION; HUMAN; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; SUDDEN DEATH;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; JAPAN; MALE; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL ANALYSIS; SURVIVORS; TREATMENT OUTCOME;

EID: 62149119563     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.145243     Document Type: Article

References (21)

1. Moss AJ, Zareba W, Hall WJ, et al, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
2. Goldenberg I, Moss AJ, McNitt S, et al., for the MADIT-II Investigators. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 2006;47:1811-7.
3. Buxton AE. Sudden death after myocardial infarction-who needs prophylaxis, and when? N Engl J Med 2005;352:2638-40.
4. Boersma E, Mercado N, Poldermans D, et al. Acute myocardial infarction. Lancet 2003;361:847-58.
5. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
6. Kasanuki H, Honda T, Haze K, et al, for the HIJAMI Investigators. A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: rationale and initial results of the HIJAMI Registry. Am Heart J 2005;150:411-8.
7. Pitta SR, Grzybowski M, Welch RD, et al. ST-segment depression on the initial electrocardiogram in acute myocardial infarction-prognostic significance and its effect on short-term mortality: a report from the national registry of myocardial infarction (NRMI-2,3,4). Am J Cardiol 2005;95:843-8.
8. Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction. The CADILLAC risk score. J Am Coll Cardiol 2005;45:1397-405.
9. Shihara M, Tsutsui H, Tsuchihashi M, et al, for the Japanese Coronary Intervention Study (JCIS) group. In-hospital and one-year outcomes for patients undergoing percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2002;90:932-6.
10. Ottervanger JP, Ramdat Misier AR, Dambrink JHE, et al, on behalf of the Zwolle Myocardial Infarction Study Group. Mortality in patients with left ventricular ejection fraction ≤30% after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol 2007;100:793-7.
11. Greenberg H, Case RB, Moss AJ, et al, for the MADIT-II Investigators. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-III. J Am Coll Cardiol 2004;43:1459-65.
12. Abildstrom SZ, Ottesen MM, Rask-Madsen C, et al, on behalf of the TRACE Study Group. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure. Int J Cardiol 2005;104:184-9.
13. Solomon SD, Zelenkofske S, McMurray JJ, et al, for the Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005;352:2581-8.
14. Tanno K, Miyoshi F, Watanabe N, et al. Are the MADIT II criteria for ICD implantation appropriate for Japanese patients? Circ J 2005;69:19-22.
15. Boden WE, MD, Eagle K, Granger CB. Reperfusion strategies in acute ST-segment elevation myocardial infarction. A comprehensive review of contemporary management options. J An Coll Cardiol 2007;50:917-29.
16. Ottervanger JP, van't Hof AWJ, Reiffers S, et al. Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J 2001;22:785-90.
17. Ndrepepa G, Mehilli J, Martinoff S, et al. Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction. J An Coll Cardiol 2007;50:149-56.
18. Yap YG, Duong T, Bland JM, et al. Optimising the dichotomy limit for left ventricular ejection fraction in selecting patients for defibrillator therapy after myocardial infarction. Heart 2007;93:832-6.
19. Santini M, Lavalle C, Ricci PP. Primary and secondary prevention of sudden cardiac death: who should get an ICD? Heart 2007;93:1478-83.
20. Hohnloser SH, Kuck KH, Dorian P, et al, on behalf of the DINAMIT Investigators. Prophylactic use of an implantable cardioverter- defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-8.
21. Bigger JT, for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmia after coronary-artery bypass graft surgery. N Engl J Med 1997;337:1569-75.